Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Applying to Kaiser Permanente-Capitol Hill Medical Center · Washington D.C., District of Columbia
Answer a few short questions to share with the research team.